Skip to main content
2026 Annual Conference Main banner

Full Schedule

  1. Home
  2. Full Schedule

Full Schedule

  • Sunday, March 22, 2026
  • 6:30 AM - 6:00 PM CT
    Registration
  • 7:30 AM - 8:00 AM CT
    Non-CE Product Showcase: Ingrezza (valbenazine) in Tardive Dyskinesia (Sponsored by Neurocrine Biosciences)
  • 8:15 AM - 9:15 AM CT
    Welcome and Networking
  • 9:15 AM - 10:00 AM CT
    Coffee Break with Exhibitors (Sponsored by UCB)
  • 9:30 AM - 9:45 AM CT
    Non-CE Pop-Up Presentation: Practical Considerations for Once-Daily Extended-Release Therapy (Sponsored by Aucta Pharmaceuticals)
  • 10:00 AM - 10:30 AM CT
    Bridging the Gap: Enhancing Cangrelor Knowledge and Neuroscience Nursing Self-Efficacy
  • 10:00 AM - 10:30 AM CT
    Comprehensive Quality Improvement in Stroke Care: Venous Thromboembolism Prevention and Depression Detection
  • 10:00 AM - 10:30 AM CT
    Standing Strong: Advancing Fall Prevention in Neuroscience Care
  • 10:00 AM - 10:30 AM CT
    Epilepsy Foundation Session: Continuous Quality Improvement: Screening for Barriers to Medication Adherence in Epilepsy
  • 10:40 AM - 11:10 AM CT
    Enhancing Care Coordination to Improve Primary Care follow up and medication adherence among acute stroke patients discharged to home
  • 10:40 AM - 11:10 AM CT
    From Blockage to Breakthrough: Carotid Surgery in an Acute Stroke Unit
  • 10:40 AM - 11:10 AM CT
    Family members’ experiences in a neurological step-down unit
  • 10:40 AM - 11:10 AM CT
    Streamlining Care, Strengthening Teams: Standardizing Triage Protocols and Practices
  • 11:20 AM - 11:50 AM CT
    A Unicorn Amongst Zebras: A Case Study on Navigating Nursing for Progressive Multifocal Leukoencephalopathy (PML)
  • 11:20 AM - 11:50 AM CT
    Training Over Territory: How Stroke Nurse Selection and Education Maintains Care Standards Across Changing Unit Environments
  • 11:20 AM - 11:50 AM CT
    Roadmap to Success: Optimizing Inpatient Staffing for a Pediatric Epilepsy Monitoring Unit to Enhance Patient Safety
  • 11:20 AM - 11:50 AM CT
    The Quiet Storm: Unmasking Nonconvulsive Seizures in Neuro Care
  • 12:00 PM - 1:00 PM CT
    Lunch with Exhibitors
  • 12:00 PM - 1:00 PM CT
    Non-CE Lunch Symposium: Targeted Therapy in mIDH Adult-Type Diffuse Glioma (Sponsored by Servier Pharmaceuticals)
  • 1:00 PM - 2:00 PM CT
    Opening Speaker: The Making of Medical Heroes: A Story of Hope, Healing, and Teamwork
  • 2:10 PM - 3:10 PM CT
    Pediatric Headache Pearls for APPs
  • 2:10 PM - 3:10 PM CT
    It’s Not Always Black and White When It Comes to Gray Matter: Case Studies on Atypical Stroke Presentation
  • 2:10 PM - 3:10 PM CT
    Paint Your Cortex
  • 2:10 PM - 3:10 PM CT
    Elevating Neuroscience Nursing: Two Hospitals, One Mission - Connecting Insight to Impact Through Collaboration
  • 3:10 PM - 3:40 PM CT
    Break with Exhibits and Posters
  • 3:15 PM - 3:30 PM CT
    Non-CE Industry Poster Presentation: Safety and Tolerability of GTX-104 (Nimodipine Injection for IV Infusion) Compared with Oral Nimodipine in Patients with Aneurysmal Subarachnoid Hemorrhage: A Prospective Randomized Trial (Sponsored by Grace Therapeutics)
  • 3:40 PM - 4:40 PM CT
    If Only I Had Known: Real-World Insights From Becoming a NP and a CNS
  • 3:40 PM - 4:40 PM CT
    3D Posterior Fossa Vessels and Confusing Stroke Symptoms
  • 3:40 PM - 4:40 PM CT
    Understanding Blunt Cerebrovascular Injuries (BCVI) and the Role Nursing Plays in Improving Patient Outcomes
  • 3:40 PM - 4:40 PM CT
    Secret Weapon Attack or Mass Psychogenic Illness? The Role of Flawed Science, Diplomatic Intrigue, and Media Sensationalism in the Continued Mystery of ‘Havana Syndrome.’
  • 4:50 PM - 5:20 PM CT
    Multimodal Monitoring: A Tiered Approach to aneurysmal Subarachnoid Hemorrhage Management in the Neuro ICU
  • 4:50 PM - 5:20 PM CT
    Mixed Messaging: FAST vs BEFAST
  • 4:50 PM - 5:20 PM CT
    Brain-Eating Ameba: A True Horror Story
  • 4:50 PM - 5:20 PM CT
    The Magic Kingdom of Sleep Medicine: Fun Facts Neuroscience Nurses Must Know about Sleep-Wake Disorders
  • 5:30 PM - 7:00 PM CT
    Opening Reception with Exhibitors and Posters
  • 5:45 PM - 6:00 PM CT
    Non-CE Industry Poster Presentation: Final Results from a Long-Term Open Label Extension Study (Up to 4 Years): Tolerability of Fenfluramine and Global Functioning of Pediatric and Adult Patients with Dravet or Lennox-Gastaut Syndromes (Sponsored by UCB, Inc.)
  • 6:00 PM - 6:30 PM CT
    Non-CE Product Showcase: Power of Awareness (Sponsored by Alexion)
  • 6:30 PM - 7:30 PM CT
    APP Reception (Sponsored by UCB, Inc.)